SEC Comment Letter 0000000000-23-013132 to DOC.COM INC. (CIK 0001925674)
DOC.COM INC. (CIK 0001925674)
Date: Dec. 1, 2023 · CIK: 0001925674 · Accession: 0000000000-23-013132
AI Filing Summary & Sentiment
File numbers found in text: 024-12337
Letter
United States securities and exchange commission logo December 1, 2023 Charles Nader Chief Executive Officer Doc.com Inc. 408 Broadway New York, NY 10013 Re:Doc.com Inc. Amendment No. 2 to Offering Statement on Form 1-A Filed November 27, 2023 File No. 024-12337 Dear Charles Nader: We have reviewed your amended offering statement and have the following comments. Please respond to this letter by amending your offering statement and providing the requested information. If you do not believe a comment applies to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response. After reviewing any amendment to your offering statement and the information you provide in response to this letter, we may have additional comments. Unless we note otherwise, any references to prior comments are to comments in our November 21, 2023 letter. Form 1-A filed November 27, 2023 Business, page 17 1.We note your response to prior comment 1 and that you "connect healthcare professionals to patients and don’t have a contract directly with healthcare professionals as a payer." However, we also note your disclosure indicating you intend to bill insurance companies, sell over-the-counter products, and appear to anticipate an active role in the doctor-patient communications. Please revise to clarify the level of involvement the company will have between patients and doctors, psychologists, and veterinarians, and to more clearly discuss the services that will be provided.
FirstName LastNameCharles Nader Comapany NameDoc.com Inc. December 1, 2023 Page 2 FirstName LastName Charles Nader Doc.com Inc. December 1, 2023 Page 2 Please contact Lauren Pierce at 202-551-3887 or Matthew Derby at 202-551-3334 with any other questions. Sincerely, Division of Corporation Finance Office of Technology cc: Andy Altahawi
Show Raw Text
United States securities and exchange commission logo
December 1, 2023
Charles Nader
Chief Executive Officer
Doc.com Inc.
408 Broadway
New York, NY 10013
Re:Doc.com Inc.
Amendment No. 2 to Offering Statement on Form 1-A
Filed November 27, 2023
File No. 024-12337
Dear Charles Nader:
We have reviewed your amended offering statement and have the following comments.
Please respond to this letter by amending your offering statement and providing the
requested information. If you do not believe a comment applies to your facts and circumstances
or do not believe an amendment is appropriate, please tell us why in your response.
After reviewing any amendment to your offering statement and the information you
provide in response to this letter, we may have additional comments. Unless we note otherwise,
any references to prior comments are to comments in our November 21, 2023 letter.
Form 1-A filed November 27, 2023
Business, page 17
1.We note your response to prior comment 1 and that you "connect healthcare professionals
to patients and don’t have a contract directly with healthcare professionals as a payer."
However, we also note your disclosure indicating you intend to bill insurance companies,
sell over-the-counter products, and appear to anticipate an active role in the doctor-patient
communications. Please revise to clarify the level of involvement the company will have
between patients and doctors, psychologists, and veterinarians, and to more clearly discuss
the services that will be provided.
FirstName LastNameCharles Nader
Comapany NameDoc.com Inc.
December 1, 2023 Page 2
FirstName LastName
Charles Nader
Doc.com Inc.
December 1, 2023
Page 2
Please contact Lauren Pierce at 202-551-3887 or Matthew Derby at 202-551-3334 with
any other questions.
Sincerely,
Division of Corporation Finance
Office of Technology
cc: Andy Altahawi